For the year ending 2025-12-31, JAZZ has $11,659,340K in assets. $1,391,899K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,391,899 | |||
| Investments | 1,050,000 | |||
| Accounts receivable, net of allowances of 17,294 and 32,691 at december 31, 2025 and 2024, respectively | 830,747 | |||
| Inventories | 416,962 | |||
| Prepaid expenses | 152,481 | |||
| Other current assets | 323,954 | |||
| Total current assets | 4,166,043 | |||
| Property, plant and equipment, net | 199,857 | |||
| Operating lease assets | 58,880 | |||
| Intangible assets, net | 4,429,510 | |||
| Goodwill | 1,829,340 | |||
| Deferred tax assets, net | 869,130 | |||
| Deferred financing costs | 7,550 | |||
| Other non-current assets | 99,030 | |||
| Total assets | 11,659,340 | |||
| Accounts payable | 122,061 | |||
| Accrued liabilities | 1,034,170 | |||
| Current portion of long-term debt | 1,029,903 | |||
| Income taxes payable | 56,387 | |||
| Total current liabilities | 2,242,521 | |||
| Long-term debt, less current portion | 4,328,354 | |||
| Operating lease liabilities, less current portion | 50,892 | |||
| Deferred tax liabilities, net | 594,470 | |||
| Other non-current liabilities | 124,519 | |||
| Ordinary shares, nominal value 0.0001 per share 300,000 shares authorized 61,435 and 60,631 shares issued and outstanding at december 31, 2025 and 2024, respectively | 6 | |||
| Non-voting euro deferred shares, 0.01 par value per share 4,000 shares authorized, issued and outstanding at both december 31, 2025 and 2024 | 55 | |||
| Capital redemption reserve | 473 | |||
| Additional paid-in capital | 4,240,472 | |||
| Accumulated other comprehensive loss | -568,598 | |||
| Retained earnings | 646,176 | |||
| Total shareholders equity | 4,318,584 | |||
| Total liabilities and shareholders equity | 11,659,340 | |||
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)